Post-Marketing Surveillance of Humira in Korean Pediatric CD Patients Under the "New-Drug Re-examination"
Phase of Trial: Phase IV
Latest Information Update: 06 Jun 2017
At a glance
- Drugs Adalimumab (Primary)
- Indications Crohn's disease
- Focus Adverse reactions
- Sponsors AbbVie
- 01 Jun 2017 Status changed from active, no longer recruiting to completed.
- 30 May 2017 Status changed from recruiting to active, no longer recruiting.
- 27 Oct 2015 New trial record